在患有高风险神经母细胞瘤的患者中,在123I MIBG扫描上出现异常扩散脑摄取的罕见病例
Deepashri Basavalingu1, Murat Sadic2, Safia Cheeney1
1From the Nuclear Medicine Resident, Department of Radiology, University of Washington School of Medicine. Corresponding author, involved in the preparation and editing of manuscript including images. Nothing to disclose.
Clinical nuclear medicine
|April 4, 2024
概括
123I-meta-iodobenzylguanidine (123I-MIBG) 扫描有助于儿童的神经母细胞瘤的发展阶段. 在一个罕见的案例中,123I-MIBG的异常脑吸收表明,由于脑膜转移,血脑屏障被破坏.
科学领域:
- 核医学是一种核医学.
- 儿科瘤学 儿科瘤学
- 放射性药物 放射性药物 放射性药物
背景情况:
- 123I-meta-iodobenzylguanidine (123I-MIBG) 是用于儿童神经母细胞瘤分期和反应评估的标准成像剂.
- 123I-MIBG的正常生理吸收发生在特定的器官中,它通常不会穿过完整的血脑屏障.
